| 1 | Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myelomaBlood, 2024, 143, 2612-2626 | 1.0 | 14 | Citations (PDF) |
| 2 | High clonal diversity and spatial genetic admixture in early prostate cancer and surrounding normal tissue | 14.2 | 7 | Citations (PDF) |
| 3 | Quantifying mRNA in Highly Degraded Fixed Tissues by Nanostring Technology: A Comparative Study | 1.9 | 0 | Citations (PDF) |
| 4 | Dysgeusia in Patients with Breast Cancer Treated with Chemotherapy—A Narrative Review | 4.6 | 29 | Citations (PDF) |
| 5 | Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience | 2.6 | 1 | Citations (PDF) |
| 6 | Implementation of Precision Oncology in the National Healthcare System: A Statement Proposal Endorsed by Italian Scientific Societies | 3.2 | 3 | Citations (PDF) |
| 7 | Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors | 7.0 | 16 | Citations (PDF) |
| 8 | Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy | 14.2 | 105 | Citations (PDF) |
| 9 | A non-dividing cell population with high pyruvate dehydrogenase kinase activity regulates metabolic heterogeneity and tumorigenesis in the intestine | 14.2 | 37 | Citations (PDF) |
| 10 | Pathological examination of breast cancer samples before and after neoadjuvant therapy: recommendations from the Italian Group for the Study of Breast Pathology - Italian Society of Pathology (GIPaM-SIAPeC) | 2.2 | 10 | Citations (PDF) |
| 11 | The Tumor-Specific Expression of L1 Retrotransposons Independently Correlates with Time to Relapse in Hormone-Negative Breast Cancer Patients | 4.8 | 2 | Citations (PDF) |
| 12 | Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial | 36.5 | 206 | Citations (PDF) |
| 13 | Memory CD8+ T cell diversity and B cell responses correlate with protection against SARS-CoV-2 following mRNA vaccination | 24.9 | 57 | Citations (PDF) |
| 14 | Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond | 14.3 | 290 | Citations (PDF) |
| 15 | Kinomic profiling of tumour xenografts derived from patients with non–small cell lung cancer confirms their fidelity and reveals potentially actionable pathways | 2.9 | 3 | Citations (PDF) |
| 16 | Optimized EGFR Blockade Strategies in <i>EGFR</i> Addicted Gastroesophageal Adenocarcinomas | 6.4 | 21 | Citations (PDF) |
| 17 | The lobular neoplasia enigma: management and prognosis in a long follow-up case series | 2.2 | 6 | Citations (PDF) |
| 18 | Personalized therapeutic strategies in HER2-driven gastric cancer | 5.1 | 20 | Citations (PDF) |
| 19 | Author’s reply: Letter to the Editor in response to Guerriero “Restriction of autopsies during the COVID-19 epidemic in Italy: prudence or fear?” | 2.2 | 0 | Citations (PDF) |
| 20 | Clinical Relevance of Tubular Breast Carcinoma: Large Retrospective Study and Meta-Analysis | 2.7 | 9 | Citations (PDF) |
| 21 | Exposure and Management of the Health Risk for the Use of Formaldehyde and Xylene in a Large Pathology Laboratory | 0.7 | 9 | Citations (PDF) |
| 22 | Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition | 14.2 | 27 | Citations (PDF) |
| 23 | INSM1 Expression in Breast Neoplasms with Neuroedocrine Features | 12.7 | 21 | Citations (PDF) |
| 24 | COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance | 14.2 | 18 | Citations (PDF) |
| 25 | Basic principles of biobanking: from biological samples to precision medicine for patients | 3.1 | 173 | Citations (PDF) |
| 26 | Evaluation of global and intragenic hypomethylation in colorectal adenomas improves patient stratification and colorectal cancer risk prediction | 4.3 | 21 | Citations (PDF) |
| 27 | Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer | 4.1 | 14 | Citations (PDF) |
| 28 | Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations | 2.6 | 20 | Citations (PDF) |
| 29 | Preoperative breast cancer staging with multi-modality imaging and surgical outcomes | 3.0 | 19 | Citations (PDF) |
| 30 | Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial | 2.7 | 153 | Citations (PDF) |
| 31 | HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction | 1.7 | 11 | Citations (PDF) |
| 32 | MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer | 2.7 | 11 | Citations (PDF) |
| 33 | Reoperation rate after breast conserving surgery as quality indicator in breast cancer treatment: A reappraisal | 2.6 | 15 | Citations (PDF) |
| 34 | Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study | 11.3 | 55 | Citations (PDF) |
| 35 | Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers | 3.7 | 10 | Citations (PDF) |
| 36 | DSCAM-AS1-Driven Proliferation of Breast Cancer Cells Involves Regulation of Alternative Exon Splicing and 3′-End Usage | 4.1 | 23 | Citations (PDF) |
| 37 | Activation of the <scp>MET</scp> receptor attenuates doxorubicin‐induced cardiotoxicity in vivo and in vitro | 6.8 | 25 | Citations (PDF) |
| 38 | Cold Formalin Fixation Guarantees DNA Integrity in Formalin Fixed Paraffin Embedded Tissues: Premises for a Better Quality of Diagnostic and Experimental Pathology With a Specific Impact on Breast Cancer | 2.7 | 36 | Citations (PDF) |
| 39 | The requirements of a specialist breast centre | 2.6 | 160 | Citations (PDF) |
| 40 | Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles | 4.1 | 9 | Citations (PDF) |
| 41 | Post‐radiotherapy vascular lesions of the breast: immunohistochemical and molecular features of 74 cases with long‐term follow‐up and literature review | 3.5 | 15 | Citations (PDF) |
| 42 | Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast Cancer | 8.6 | 0 | Citations (PDF) |
| 43 | The 2019 World Health Organization classification of tumours of the breast | 3.5 | 698 | Citations (PDF) |
| 44 | “Metastatic Cancer of Unknown Primary” or “Primary Metastatic Cancer”? | 2.7 | 51 | Citations (PDF) |
| 45 | The autopsy debate during the COVID-19 emergency: the Italian experience | 3.1 | 54 | Citations (PDF) |
| 46 | AR/ER Ratio Correlates with Expression of Proliferation Markers and with Distinct Subset of Breast Tumors | 4.8 | 26 | Citations (PDF) |
| 47 | Cancer of Unknown Primary (
<scp>CUP</scp>
): genetic evidence for a novel nosological entity? A case report | 7.2 | 10 | Citations (PDF) |
| 48 | Reverse signaling by semaphorin 4C elicits SMAD1/5- and ID1/3-dependent invasive reprogramming in cancer cells | 6.0 | 26 | Citations (PDF) |
| 49 | CUTseq is a versatile method for preparing multiplexed DNA sequencing libraries from low-input samples | 14.2 | 16 | Citations (PDF) |
| 50 | BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories | 3.3 | 3 | Citations (PDF) |
| 51 | A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell–Intrinsic Transcriptional MSI Traits | 0.6 | 74 | Citations (PDF) |
| 52 | Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives | 5.3 | 63 | Citations (PDF) |
| 53 | Tissues under-vacuum to overcome suboptimal preservation | 5.2 | 13 | Citations (PDF) |
| 54 | Integration of Ki-67 index into AJCC 2018 staging provides additional prognostic information in breast tumours candidate for genomic profiling | 5.8 | 19 | Citations (PDF) |
| 55 | Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma | 2.4 | 13 | Citations (PDF) |
| 56 | High USP6NL Levels in Breast Cancer Sustain Chronic AKT Phosphorylation and GLUT1 Stability Fueling Aerobic Glycolysis | 0.6 | 70 | Citations (PDF) |
| 57 | Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts | 7.3 | 22 | Citations (PDF) |
| 58 | RollFISH achieves robust quantification of single-molecule RNA biomarkers in paraffin-embedded tumor tissue samples | 4.6 | 33 | Citations (PDF) |
| 59 | PARP Inhibitors in Ovarian Cancer | 2.6 | 136 | Citations (PDF) |
| 60 | The Dilemma of HER2 Double-equivocal Breast Carcinomas | 3.9 | 27 | Citations (PDF) |
| 61 | Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study | 2.5 | 44 | Citations (PDF) |
| 62 | FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients | 3.0 | 35 | Citations (PDF) |
| 63 | miR‐205 mediates adaptive resistance to
<scp>MET</scp>
inhibition via
<scp>ERRFI</scp>
1 targeting and raised
<scp>EGFR</scp>
signaling | 7.2 | 26 | Citations (PDF) |
| 64 | The expression of LINE1‐<i>MET</i> chimeric transcript identifies a subgroup of aggressive breast cancers | 4.5 | 27 | Citations (PDF) |
| 65 | Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy. | 5.6 | 30 | Citations (PDF) |
| 66 | Eosinophilia – associated basal plasmacytosis: an early and sensitive histologic feature of inflammatory bowel diseaseApmis, 2017, 125, 179-183 | 2.6 | 23 | Citations (PDF) |
| 67 | Prognostic role of maspin expression in melanoma: probably far from clinical use | 3.5 | 3 | Citations (PDF) |
| 68 | Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis | 5.8 | 21 | Citations (PDF) |
| 69 | The expression of GHRH and its receptors in breast carcinomas with apocrine differentiation—further evidence of the presence of a GHRH pathway in these tumors | 2.4 | 10 | Citations (PDF) |
| 70 | Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases | 6.5 | 25 | Citations (PDF) |
| 71 | Cell-cycle Progression-score Might Improve the Current Risk Assessment in Newly Diagnosed Prostate Cancer Patients | 1.2 | 22 | Citations (PDF) |
| 72 | Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene | 5.8 | 7 | Citations (PDF) |
| 73 | Primary tumor location predicts the site of local relapse after nipple–areola complex (NAC) sparing mastectomy | 2.5 | 20 | Citations (PDF) |
| 74 | The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries | 14.2 | 28 | Citations (PDF) |
| 75 | The genetic landscape of breast carcinomas with neuroendocrine differentiation | 4.8 | 67 | Citations (PDF) |
| 76 | Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function | 23.8 | 92 | Citations (PDF) |
| 77 | <scp>ASPM</scp>
and
<scp>CITK</scp>
regulate spindle orientation by affecting the dynamics of astral microtubules | 5.2 | 14 | Citations (PDF) |
| 78 | Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study | 2.0 | 13 | Citations (PDF) |
| 79 | Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases | 2.7 | 65 | Citations (PDF) |
| 80 | Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer | 5.2 | 17 | Citations (PDF) |
| 81 | Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells | 6.4 | 37 | Citations (PDF) |
| 82 | Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples | 2.5 | 34 | Citations (PDF) |
| 83 | Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification | 11.3 | 4 | Citations (PDF) |
| 84 | Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization | 1.7 | 29 | Citations (PDF) |
| 85 | The impact of malignant nipple discharge cytology (NDc) in surgical management of breast cancer patients | 2.5 | 5 | Citations (PDF) |
| 86 | Androgen receptor status predicts development of brain metastases in ovarian cancers | 1.7 | 17 | Citations (PDF) |
| 87 | Tamoxifen Treatment of Breast Cancer Cells: Impact on Hedgehog/GLI1 Signaling | 4.5 | 25 | Citations (PDF) |
| 88 | The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank | 2.5 | 46 | Citations (PDF) |
| 89 | Glycerolized Reticular Dermis as a New Human Acellular Dermal Matrix: An Exploratory Study | 2.5 | 9 | Citations (PDF) |
| 90 | An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer | 3.1 | 12 | Citations (PDF) |
| 91 | Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up | 2.5 | 181 | Citations (PDF) |
| 92 | Towards a formalin-free hospital. Levels of 15-F2t-isoprostane and malondialdehyde to monitor exposure to formaldehyde in nurses from operating theatres | 2.1 | 21 | Citations (PDF) |
| 93 | <scp>ASPM</scp>
and
<scp>CITK</scp>
regulate spindle orientation by affecting the dynamics of astral microtubules | 5.2 | 74 | Citations (PDF) |
| 94 | Digital breast tomosynthesis as an adjunct to digital mammography for detecting and characterising invasive lobular cancers: a multi-reader study | 1.1 | 42 | Citations (PDF) |
| 95 | Omission of axillary dissection after a positive sentinel lymph-node: Implications in the multidisciplinary treatment of operable breast cancer | 10.0 | 9 | Citations (PDF) |
| 96 | Consistency in recognizing microinvasion in breast carcinomas is improved by immunohistochemistry for myoepithelial markers | 3.1 | 15 | Citations (PDF) |
| 97 | Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort | 6.7 | 28 | Citations (PDF) |
| 98 | MALAT1 Long Non-coding RNA Expression in Thyroid Tissues: Analysis by In Situ Hybridization and Real-Time PCR | 12.7 | 56 | Citations (PDF) |
| 99 | Predictive Diagnostic Pathology in the Target Therapy Era in Breast Cancer | 2.0 | 15 | Citations (PDF) |
| 100 | Interpretation of p16<sup>INK4a</sup>/Ki‐67 dual immunostaining for the triage of human papillomavirus‐positive women by experts and nonexperts in cervical cytology | 2.7 | 37 | Citations (PDF) |
| 101 | Meningeal carcinomatosis underdiagnosis and overestimation: incidence in a large consecutive and unselected population of breast cancer patients | 3.0 | 25 | Citations (PDF) |
| 102 | Elaboration of a nomogram to predict non sentinel node status in breast cancer patients with positive sentinel node, intra-operatively assessed with one step nucleic acid amplification method | 11.3 | 15 | Citations (PDF) |
| 103 | A rare case of breast cancer showing distinct <scp>TTF</scp>‐1 nuclear expression: small‐cell carcinoma or not? | 3.5 | 2 | Citations (PDF) |
| 104 | Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas | 1.7 | 25 | Citations (PDF) |
| 105 | Mammary carcinomas with neuroendocrine features – correct understanding and proper use of the terminology | 3.5 | 2 | Citations (PDF) |
| 106 | Flexible Lab-Tailored Cut-Offs for Suitability of Formalin-Fixed Tumor Samples for Diagnostic Mutational Analyses | 2.5 | 9 | Citations (PDF) |
| 107 | Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues | 3.7 | 35 | Citations (PDF) |
| 108 | TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin | 1.3 | 50 | Citations (PDF) |
| 109 | International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013) | 2.0 | 49 | Citations (PDF) |
| 110 | The Perfect Pathology Report After Neoadjuvant Therapy | 2.0 | 16 | Citations (PDF) |
| 111 | Well-differentiated neuroendocrine tumor of the breast with recurrence due to needle tract seeding | 3.1 | 11 | Citations (PDF) |
| 112 | In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications | 12.7 | 48 | Citations (PDF) |
| 113 | Digital Breast Tomosynthesis (DBT) to Characterize MRI-Detected Additional Lesions Unidentified at Targeted Ultrasound in Newly Diagnosed Breast Cancer Patients | 3.9 | 23 | Citations (PDF) |
| 114 | Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast | 2.4 | 51 | Citations (PDF) |
| 115 | Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status | 4.8 | 71 | Citations (PDF) |
| 116 | <i>
<scp>SF3B1</scp>
</i>
mutations constitute a novel therapeutic target in breast cancer | 4.8 | 181 | Citations (PDF) |
| 117 | The diagnosis of inflammatory bowel disease is often unsupported in clinical practice | 1.1 | 13 | Citations (PDF) |
| 118 | Current Projects in Pre-analytics: Where to Go? | 0.0 | 6 | Citations (PDF) |
| 119 | Efficiency of a Preoperative Axillary Ultrasound and Fine-Needle Aspiration Cytology to Detect Patients with Extensive Axillary Lymph Node Involvement | 2.5 | 18 | Citations (PDF) |
| 120 | Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study | 2.5 | 36 | Citations (PDF) |
| 121 | Gene Status in <i>HER2</i> Equivocal Breast Carcinomas: Impact of Distinct Recommendations and Contribution of a Polymerase Chain Reaction-Based Method | 3.6 | 38 | Citations (PDF) |
| 122 | Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma | 4.9 | 76 | Citations (PDF) |
| 123 | A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue | 3.7 | 49 | Citations (PDF) |
| 124 | Well‐differentiated neuroendocrine tumour of the breast showing peculiar endovascular spread | 3.5 | 10 | Citations (PDF) |
| 125 | Cytomorphologic and molecular features of hobnail variant of papillary thyroid carcinoma: Case series and literature review | 1.1 | 52 | Citations (PDF) |
| 126 | Morgana acts as a proto‐oncogene through inhibition of a <scp>ROCK–PTEN</scp> pathway | 4.8 | 23 | Citations (PDF) |
| 127 | Prognostic factors in a multicentre study of 247 atypical pulmonary carcinoids | 1.4 | 56 | Citations (PDF) |
| 128 | Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells | 3.0 | 23 | Citations (PDF) |
| 129 | Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis | 1.4 | 39 | Citations (PDF) |
| 130 | Identification of novel non‐coding RNA‐based negative feedback regulating the expression of the oncogenic transcription factor GLI1 | 4.2 | 33 | Citations (PDF) |
| 131 | Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast | 4.8 | 95 | Citations (PDF) |
| 132 | E15. HER2 assessment in breast cancer | 2.9 | 0 | Citations (PDF) |
| 133 | Potential biomarkers of long‐term benefit from single‐agent trastuzumab or lapatinib in HER2‐positive metastatic breast cancer | 4.2 | 41 | Citations (PDF) |
| 134 | Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy | 2.6 | 25 | Citations (PDF) |
| 135 | Primary systemic treatment and concomitant low dose radiotherapy for breast cancer: Final results of a prospective phase II study | 2.6 | 12 | Citations (PDF) |
| 136 | A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer | 1.7 | 22 | Citations (PDF) |
| 137 | MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue | 2.8 | 98 | Citations (PDF) |
| 138 | E04. Balancing between classic morphology and molecular medicine | 2.9 | 0 | Citations (PDF) |
| 139 | Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values | 2.6 | 54 | Citations (PDF) |
| 140 | Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role? | 1.7 | 75 | Citations (PDF) |
| 141 | The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling | 16.8 | 106 | Citations (PDF) |
| 142 | “To Be or Not to Be in a Good Shape”: Diagnostic and Clinical Value of Nuclear Shape Irregularities in Thyroid and Breast Cancer | 8.0 | 26 | Citations (PDF) |
| 143 | Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma | 2.5 | 41 | Citations (PDF) |
| 144 | Accuracy of tumour size assessment in the preoperative staging of breast cancer: comparison of digital mammography, tomosynthesis, ultrasound and MRI | 4.2 | 94 | Citations (PDF) |
| 145 | International multicenter tool to predict the risk of four or more tumor-positive axillary lymph nodes in breast cancer patients with sentinel node macrometastases | 2.5 | 43 | Citations (PDF) |
| 146 | A simple and reproducible prognostic index in luminal ER-positive breast cancers | 1.2 | 24 | Citations (PDF) |
| 147 | Spontaneous and pronase‐induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines | 4.8 | 18 | Citations (PDF) |
| 148 | Gene expression profiling in breast cancer: A clinical perspective | 2.6 | 82 | Citations (PDF) |
| 149 | p130Cas alters the differentiation potential of mammary luminal progenitors by deregulating c-Kit activity | 3.3 | 17 | Citations (PDF) |
| 150 | Are Breast Cancer Molecular Classes Predictive of Survival in Patients with Long Follow-Up? | 1.7 | 15 | Citations (PDF) |
| 151 | Pituitary metastasis of an unknown neuroendocrine breast carcinoma mimicking a pituitary adenoma | 0.5 | 9 | Citations (PDF) |
| 152 | Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues | 2.7 | 84 | Citations (PDF) |
| 153 | Small‐cell carcinoma of the breast with squamous differentiation | 3.5 | 6 | Citations (PDF) |
| 154 | A “Weighted” Fluorescence In Situ Hybridization Strengthens the Favorable Prognostic Value of 1p/19q Codeletion in Pure and Mixed Oligodendroglial Tumors | 1.9 | 17 | Citations (PDF) |
| 155 | Search for Neuro-Endocrine Markers (Chromogranin A, Synaptophysin and VGF) in Breast Cancers. An integrated Approach Using Immunohistochemistry and Gene Expression Profiling | 12.7 | 22 | Citations (PDF) |
| 156 | A Collection of Primary Tissue Cultures of Tumors from Vacuum Packed and Cooled Surgical Specimens: A Feasibility Study | 2.5 | 29 | Citations (PDF) |
| 157 | Inflammatory bowel disease: A proposal to facilitate the achievement of an unequivocal diagnosis | 4.7 | 7 | Citations (PDF) |
| 158 | International Multicenter Tool to Predict the Risk of Nonsentinel Node Metastases in Breast Cancer | 5.2 | 77 | Citations (PDF) |
| 159 | Critical Steps in Tissue Processing in Histopathology | 0.7 | 28 | Citations (PDF) |
| 160 | Reliability of Whole Sentinel Lymph Node Analysis by One-Step Nucleic Acid Amplification for Intraoperative Diagnosis of Breast Cancer Metastases | 5.0 | 61 | Citations (PDF) |
| 161 | Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer | 2.4 | 30 | Citations (PDF) |
| 162 | Comparison of Anti–Estrogen Receptor Antibodies SP1, 6F11, and 1D5 in Breast Cancer | 0.6 | 29 | Citations (PDF) |
| 163 | High-Throughput Molecular Analysis from Leftover of Fine Needle Aspiration Cytology of Mammographically Detected Breast Cancer | 3.8 | 16 | Citations (PDF) |
| 164 | Neoadjuvant chemo-radiotherapy for locally advanced esophageal cancer: A monocentric study | 1.6 | 6 | Citations (PDF) |
| 165 | HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast | 3.0 | 162 | Citations (PDF) |
| 166 | Human achaete-scute homolog-1 expression in neuroendocrine breast carcinoma | 3.1 | 9 | Citations (PDF) |
| 167 | Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis | 3.5 | 58 | Citations (PDF) |
| 168 | Hormone‐receptor expression and activity of trastuzumab with chemotherapy in HER2‐positive advanced breast cancer patients | 4.3 | 62 | Citations (PDF) |
| 169 | A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer | 26.3 | 890 | Citations (PDF) |
| 170 | Distinction of isolated tumour cells and micrometastasis in lymph nodes of breast cancer patients according to the new Tumour Node Metastasis (TNM) definitions | 2.9 | 20 | Citations (PDF) |
| 171 | Formalin Fixation at Low Temperature Better Preserves Nucleic Acid Integrity | 2.5 | 91 | Citations (PDF) |
| 172 | Obstructive Colon Metastases from Lobular Breast Cancer: Report of a Case and Review of the Literature | 1.6 | 20 | Citations (PDF) |
| 173 | Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: A single centre observational cohort study | 2.1 | 37 | Citations (PDF) |
| 174 | Biopsia percutanea vacuum assistita nelle lesioni mammarie non palpabili: analisi dell’efficacia e dei costi su 602 casi in cinque anni di esperienza | 4.2 | 15 | Citations (PDF) |
| 175 | B3 core biopsies should be assumed as positive findings for accuracy purposes | 4.2 | 2 | Citations (PDF) |
| 176 | The Pathologic Complete Response Open Question in Primary Therapy | 2.0 | 30 | Citations (PDF) |
| 177 | International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010) | 2.0 | 64 | Citations (PDF) |
| 178 | Tissue Microarray (TMA) 2011, , 23-26 | | 1 | Citations (PDF) |
| 179 | Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers | 2.5 | 181 | Citations (PDF) |
| 180 | Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison | 3.0 | 13 | Citations (PDF) |
| 181 | Molecular signaling operated by a diet‐compatible mixture of oxysterols in up‐regulating CD36 receptor in CD68 positive cells | 4.1 | 29 | Citations (PDF) |
| 182 | p140Cap dual regulation of E-cadherin/EGFR cross-talk and Ras signalling in tumour cell scatter and proliferation | 6.7 | 63 | Citations (PDF) |
| 183 | Chemotherapy with or without trastuzumab | 1.2 | 9 | Citations (PDF) |
| 184 | Nodal-Stage Classification in Invasive Lobular Breast Carcinoma: Influence of Different Interpretations of the pTNM Classification | 14.2 | 19 | Citations (PDF) |
| 185 | Teratocarcinoma-Derived Growth Factor-1 Is Upregulated in Aldosterone-Producing Adenomas and Increases Aldosterone Secretion and Inhibits Apoptosis In Vitro | 6.3 | 45 | Citations (PDF) |
| 186 | Azathioprine, Mucosal Healing in Ulcerative Colitis, and the Chemoprevention of Colitic Cancer: A Clinical-Practice-Based Forecast | 1.6 | 31 | Citations (PDF) |
| 187 | Underuse of Anthracyclines in Women with HER-2+ Advanced Breast Cancer | 3.6 | 8 | Citations (PDF) |
| 188 | A rapid scoring technique for<i>HER2</i>assessment following silver in situ hybridisation is accurate, robust and reliable | 1.7 | 1 | Citations (PDF) |
| 189 | Neuroendocrine differentiation in breast cancer: established facts and unresolved problems | 3.4 | 114 | Citations (PDF) |
| 190 | HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib | 2.5 | 49 | Citations (PDF) |
| 191 | Neuroendocrine Differentiation Patterns in Various Organs (Including Lung, Breast, Skin and Urogenital Tract) 2010, , 415-428 | | 0 | Citations (PDF) |
| 192 | Anti-HER2 Treatment and Breast Cancer: State of the Art, Recent Patents, and New Strategies | 2.6 | 18 | Citations (PDF) |
| 193 | Endothelial cell differentiation of human breast tumour stem/progenitor cells | 4.1 | 140 | Citations (PDF) |
| 194 | Technical limits of comparison of step‐sectioning,immunohistochemistry and RT‐PCR on breast cancer sentinel nodes: a study on methacarn‐fixed tissue | 4.1 | 23 | Citations (PDF) |
| 195 | Mixed micropapillary–ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components | 4.8 | 75 | Citations (PDF) |
| 196 | Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence <i>in situ</i> hybridization and microarray‐based CGH analysis | 4.8 | 193 | Citations (PDF) |
| 197 | Columnar cell lesions associated with breast calcifications on vacuum-assisted core biopsies: clinical, radiographic, and histological correlations | 4.9 | 62 | Citations (PDF) |
| 198 | The 17-year single-center experience with the use of azathioprine to maintain remission in ulcerative colitis | 6.8 | 11 | Citations (PDF) |
| 199 | Radical resection of a giant, invasive and symptomatic malignant Solitary Fibrous Tumour (SFT) of the pleura | 2.0 | 23 | Citations (PDF) |
| 200 | Imatinib inhibits in vitro proliferation of cells derived from a pleural solitary fibrous tumor expressing platelet-derived growth factor receptor-beta | 2.0 | 22 | Citations (PDF) |
| 201 | Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer | 1.1 | 77 | Citations (PDF) |
| 202 | Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study | 4.9 | 24 | Citations (PDF) |
| 203 | Pleomorphism of the nuclear envelope in breast cancer: a new approach to an old problem | 4.1 | 79 | Citations (PDF) |
| 204 | Vinorelbine-based salvage therapy in HER2-positive metastatic breast cancer patients progressing during trastuzumab-containing regimens: a retrospective study | 3.0 | 8 | Citations (PDF) |
| 205 | Retrospective Evaluation of Clinical Outcomes in Patients with HER2-Positive Advanced Breast Cancer Progressing on Trastuzumab-Based Therapy in the Pre-Lapatinib Era | 2.4 | 26 | Citations (PDF) |
| 206 | Gefitinib (ZD1839): Therapy in selected patients with non-small cell lung cancer (NSCLC)? | 2.0 | 22 | Citations (PDF) |
| 207 | Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions | 2.9 | 67 | Citations (PDF) |
| 208 | Biology, prognosis and response to therapy of breast carcinomas according to HER2 score | 1.2 | 32 | Citations (PDF) |
| 209 | Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases | 2.5 | 0 | Citations (PDF) |
| 210 | Misclassification of breast cancer as cause of death in a service screening area | 1.8 | 33 | Citations (PDF) |
| 211 | Insulated-Tip Knife Endoscopic Mucosal Resection of Large Colorectal Polyps Unsuitable for Standard Polypectomy | 0.4 | 40 | Citations (PDF) |
| 212 | Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin® are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating study | 1.2 | 12 | Citations (PDF) |
| 213 | Myxoid Renal Tumor With Myoepithelial Differentiation Mimicking a Salivary Gland Pleomorphic Adenoma: Description of a Case | 3.9 | 10 | Citations (PDF) |
| 214 | Validation of clinical prediction rules for a low probability of nonsentinel and extensive lymph node involvement in breast cancer patients | 1.9 | 13 | Citations (PDF) |
| 215 | Sentinel lymph node biopsy and non-sentinel node involvement in special type breast carcinomas with a good prognosis | 2.9 | 13 | Citations (PDF) |
| 216 | A quality assurance exercise to evaluate the accuracy and reproducibility of chromogenic in situ hybridisation for HER2 analysis in breast cancer | 1.7 | 19 | Citations (PDF) |
| 217 | Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens | 1.7 | 54 | Citations (PDF) |
| 218 | Lymphoscintigraphic localization of sentinel node in early colorectal cancer: Results of a monocentric study | 1.7 | 15 | Citations (PDF) |
| 219 | Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study | 2.4 | 84 | Citations (PDF) |
| 220 | Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study | 2.0 | 33 | Citations (PDF) |
| 221 | The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases | 0.8 | 32 | Citations (PDF) |
| 222 | Oxytocin synthesis within the normal and neoplastic breast: First evidence of a local peptide source | 3.6 | 9 | Citations (PDF) |
| 223 | Isolation and characterization of human breast tumor-derived endothelial cells | 2.5 | 34 | Citations (PDF) |
| 224 | Estrogen receptor-β is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast | 4.9 | 84 | Citations (PDF) |
| 225 | Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure | 3.1 | 68 | Citations (PDF) |
| 226 | Discriminating between micrometastases and isolated tumor cells in a regional and institutional setting | 2.6 | 26 | Citations (PDF) |
| 227 | Oxytocin Induces Proliferation and Migration in Immortalized Human Dermal Microvascular Endothelial Cells and Human Breast Tumor-Derived Endothelial Cells | 2.9 | 73 | Citations (PDF) |
| 228 | p130Cas as a New Regulator of Mammary Epithelial Cell Proliferation, Survival, and HER2-Neu Oncogene–Dependent Breast Tumorigenesis | 0.6 | 127 | Citations (PDF) |
| 229 | The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma | 1.7 | 77 | Citations (PDF) |
| 230 | Panenteric IBD-Like Disease in a Patient with Regressive Autism Shown for the First Time by the Wireless Capsule Enteroscopy: Another Piece in the Jigsaw of this Gut-Brain Syndrome? | 0.4 | 17 | Citations (PDF) |
| 231 | Calorie restriction protects against age‐related rat aorta sclerosis | 0.7 | 55 | Citations (PDF) |
| 232 | A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer | 5.8 | 28 | Citations (PDF) |
| 233 | Early diagnosis, not differential treatment, explains better survival in service screening | 2.9 | 46 | Citations (PDF) |
| 234 | Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology | 1.7 | 150 | Citations (PDF) |
| 235 | Prostatic Duct Carcinoma with Combined Prostatic Duct Adenocarcinoma and Urothelial Carcinoma Features | 1.0 | 6 | Citations (PDF) |
| 236 | Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union—an inter-laboratory study | 3.1 | 43 | Citations (PDF) |
| 237 | Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer | 0.4 | 261 | Citations (PDF) |
| 238 | Bronchiolar columnar cell dysplasia—genetic analysis of a novel preneoplastic lesion of peripheral lung | 3.1 | 40 | Citations (PDF) |
| 239 | Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management | 5.8 | 144 | Citations (PDF) |
| 240 | Estrogen Receptor α Is a Novel Marker Expressed by Follicular Dendritic Cells in Lymph Nodes and Tumor-Associated Lymphoid Infiltrates | 3.5 | 52 | Citations (PDF) |
| 241 | Role of CD31/Platelet Endothelial Cell Adhesion Molecule-1 Expression in in Vitro and in Vivo Growth and Differentiation of Human Breast Cancer Cells | 3.5 | 42 | Citations (PDF) |
| 242 | Heterogeneous versus homogeneous genetic nature of multiple foci of in situ carcinoma of the breast | 2.4 | 10 | Citations (PDF) |
| 243 | Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines | 2.9 | 191 | Citations (PDF) |
| 244 | Functional, Structural, and Distribution Analysis of the Chorionic Gonadotropin Receptor Using Murine Monoclonal Antibodies | 4.5 | 16 | Citations (PDF) |
| 245 | Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserumBlood, 2002, 100, 3782-3789 | 1.0 | 74 | Citations (PDF) |
| 246 | Steroid hormone receptor in pleural solitary fibrous tumours and CD34+ progenitor stromal cells | 4.8 | 47 | Citations (PDF) |
| 247 | Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance | 6.7 | 421 | Citations (PDF) |
| 248 | Ex Vivo Host Response to Gastrointestinal Cancer Cells Presented by Autologous Dendritic Cells | 1.8 | 17 | Citations (PDF) |
| 249 | Activation of Functional Oxytocin Receptors Stimulates Cell Proliferation in Human Trophoblast and Choriocarcinoma Cell Lines* | 2.7 | 54 | Citations (PDF) |
| 250 | Title is missing! | 1.0 | 7 | Citations (PDF) |
| 251 | Expression of CD31 by cells of extensive ductalin situ and invasive carcinomas of the breast | 4.8 | 46 | Citations (PDF) |
| 252 | Expression of Apocrine Differentiation Markers in Neuroendocrine Breast Carcinomas of Aged Women | 4.9 | 115 | Citations (PDF) |
| 253 | Activation of Functional Oxytocin Receptors Stimulates Cell Proliferation in Human Trophoblast and Choriocarcinoma Cell Lines | 2.7 | 24 | Citations (PDF) |
| 254 | Large Cell Neuroendocrine Carcinoma of the Gallbladder | 3.9 | 78 | Citations (PDF) |
| 255 | Mammographically detected in situ lobular carcinomas of the breast | 3.1 | 93 | Citations (PDF) |
| 256 | What modifies the relation between tumour size and lymph node metastases in T1 breast carcinomas? | 1.7 | 28 | Citations (PDF) |
| 257 | Presence and significance of oxytocin receptors in human neuroblastomas and glial tumors 1998, 77, 695-700 | | 67 | Citations (PDF) |
| 258 | Diagnostic cytological features of neuroendocrine differentiated carcinoma of the breast | 3.1 | 37 | Citations (PDF) |
| 259 | Potential Angiogenic Role of Platelet-Activating Factor in Human Breast Cancer | 3.5 | 61 | Citations (PDF) |
| 260 | Presence and significance of oxytocin receptors in human neuroblastomas and glial tumors | 4.5 | 2 | Citations (PDF) |
| 261 | Antiproliferative Effect of Oxytocin through Specific Oxytocin Receptors in Human Neuroblastoma and Astrocytoma Cell Lines | 8.0 | 5 | Citations (PDF) |
| 262 | Malignant Phyllodes Tumor of Breast with Lung Metastases Mimicking the Primary | 3.9 | 28 | Citations (PDF) |
| 263 | Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cellsvia cyclic adenosine monophosphate and protein kinase A 1997, 72, 340-344 | | 78 | Citations (PDF) |
| 264 | Diagnosis of actinomycosis by fine-needle aspiration | 1.5 | 7 | Citations (PDF) |
| 265 | Lipomatous changes in adrenocortical adenomas: Report of two cases | 12.7 | 13 | Citations (PDF) |
| 266 | Oxytocin and oxytocin-analogue F314 inhibit cell proliferation and tumor growth of rat and mouse mammary carcinomas 1996, 66, 817-820 | | 48 | Citations (PDF) |
| 267 | Lymphoepithelial cyst of the pancreas: radiological and pathological findings | 3.9 | 2 | Citations (PDF) |
| 268 | Pseudoangiosarcomatous Features in Medullary Carcinoma of the Thyroid | 1.0 | 10 | Citations (PDF) |
| 269 | Mitogenic effect of the 15‐kDa gross cystic disease fluid protein (GCDFP‐15) on breast‐cancer cell lines and on immortal mammary cells | 4.5 | 30 | Citations (PDF) |
| 270 | Fine-needle Aspiration Biopsy of the Thyroid | 1.0 | 4 | Citations (PDF) |
| 271 | PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast | 3.1 | 55 | Citations (PDF) |
| 272 | Oxytocin inhibits proliferation of human breast cancer cell lines | 3.1 | 75 | Citations (PDF) |
| 273 | Immunophenotypic properties and estrogen dependency of budding cell structures in the developing mouse mammary gland | 2.4 | 42 | Citations (PDF) |
| 274 | Oxytocin enhances myoepithelial cell differentiation and proliferation in the mouse mammary gland | 2.7 | 29 | Citations (PDF) |
| 275 | Cytologic Features of Poorly Differentiated ‘Insular‚ Carcinoma of the Thyroid, as Revealed by Fine-Needle Aspiration Biopsy | 0.6 | 94 | Citations (PDF) |
| 276 | Extraskeletal Ewing's tumor with translocation t(11;22) in a patient with Down syndrome | 1.0 | 19 | Citations (PDF) |
| 277 | A combined glucagonoma and VIPoma syndrome: First pathologic and clinical report | 4.3 | 7 | Citations (PDF) |
| 278 | Endocrine Markers in Argyrophilic Carcinomas of the Breast | 3.9 | 58 | Citations (PDF) |
| 279 | Effects of estrogens on the testis of transsexuals: A pathological and immunocytochemical study | 1.3 | 58 | Citations (PDF) |
| 280 | Binding of antibodies against human prealbumin to intestinal and bronchial carcinoids and to pancreatic endocrine tumours | 0.0 | 12 | Citations (PDF) |
| 281 | Biosafety in surgical pathology in the era of SARS-Cov2 pandemia. A statement of the Italian Society of Surgical Pathology and Cytology | 2.2 | 22 | Citations (PDF) |
| 282 | What are the priorities of pathologists’ activities during COVID-19 emergency? | 2.2 | 11 | Citations (PDF) |
| 283 | Survey on postmortem screening and management of COVID-19 related deaths | 2.2 | 1 | Citations (PDF) |
